Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

<< < Results 21 - 30 of 125 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Diabetic Nephropathies 10997922 Overexpression of GFAT activates PAI-1 promoter in mesangial cells. unassigned 0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Hyperglycemia 10997922 Overexpression of GFAT activates PAI-1 promoter in mesangial cells. unassigned 0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Glucose Intolerance 11118009 Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. causal interaction
ongoing research
unassigned
3
1
0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Hyperlipidemias 11118009 Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. causal interaction
ongoing research
unassigned
3
1
0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Obesity 11118009 Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. causal interaction
ongoing research
unassigned
3
1
0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Insulin Resistance 11167021 Cloning and characterization of mouse glutamine:fructose-6-phosphate amidotransferase 2 gene promoter. causal interaction
unassigned
1
0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Diabetes Complications 11587069 Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle. ongoing research
therapeutic application
unassigned
1
1
0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Insulin Resistance 11587069 Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle. ongoing research
therapeutic application
unassigned
1
1
0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Adenoviridae Infections 11679416 A novel variant of glutamine: fructose-6-phosphate amidotransferase-1 (GFAT1) mRNA is selectively expressed in striated muscle. ongoing research
unassigned
2
0
Show all pathways known for 2.6.1.16Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.16Diabetes Mellitus, Type 2 11902440 From Lobry de Bruyn to enzyme-catalyzed ammonia channelling: molecular studies of D-glucosamine-6P synthase. therapeutic application
unassigned
1
0
<< < Results 21 - 30 of 125 > >>